Nathan D. Jorgensen - 06 Feb 2024 Form 4 Insider Report for Vor Biopharma Inc. (VOR)

Role
CHIEF FINANCIAL OFFICER
Signature
/s/ Katie Kazem, Attorney-in-Fact
Issuer symbol
VOR
Transactions as of
06 Feb 2024
Transactions value $
-$2,285
Form type
4
Date filed
08 Feb 2024, 17:06
Previous filing
31 Jan 2024
Next filing
05 Mar 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VOR Common Stock Tax liability -$2.29K -985 -0.5% $2.32 197K 06 Feb 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares were withheld to satisfy the Reporting Person's tax withholding obligations in connection with the settlement of restricted stock units.